Neurology Department

The Neurodegenerative Disease Department of Beijing Tiantan Hospital is composed of specialists who are mainly engaged in clinical research on Parkinson's disease and Alzheimer's disease. It is at the forefront of the country in the clinical diagnosis and treatment of neurological degenerative diseases such as Parkinson's disease, movement disorders and Alzheimer's disease.

This specialty is the first in China to develop a number of advanced diagnostic technologies and new treatment methods, and is committed to providing advanced, comprehensive, reasonable and effective diagnosis and treatment plans for patients with Parkinson's disease, movement disorders, Alzheimer's disease and other diseases.

Major new clinical technologies developed in this specialty

1. Early and accurate diagnosis of Parkinson’s disease

Apply new imaging technology and standardized drug evaluation technology to accurately diagnose Parkinson's disease early and early.

This specialty applies brain molecular imaging technology, new nuclear magnetic imaging technology, electromyography tremor analysis technology, substantia nigra ultrasonic detection technology, standardized stepwise dopaminergic drug evaluation technology, etc., all of which are currently internationally advanced diagnostic technologies.

2. Apply brain pacemaker technology to comprehensively treat late-stage Parkinson's disease. This specialty collaborates with functional neurosurgery and uses systematic evaluation methods to rationally select patients with middle-late stage Parkinson's disease who are suitable for brain pacemaker surgery;

Systematic adjustments to drugs and brain pacemakers are made to patients after brain pacemaker surgery, striving to optimize the efficacy.

3. Apply non-invasive repetitive transcranial magnetic stimulation technology to treat Parkinson's disease and Parkinson's syndrome. Repetitive transcranial stimulation technology is a non-invasive, safe and effective new technology. It has a neuromodulatory effect on patients with Parkinson's disease and Parkinson's syndrome and can improve many refractory symptoms of Parkinson's patients.

4. Early diagnosis and differential diagnosis of various types of dementia and mental retardation diseases use blood, cerebrospinal fluid, intelligence assessment scales, and new molecular imaging technology to early diagnose mild cognitive impairment, various types of dementia and mental retardation diseases, accurately classify them, and provide reasonable treatment.

5. Long-term diagnosis, treatment and follow-up of chronic diseases such as Parkinson's disease and Alzheimer's disease. Establish a medical record file and follow-up system for patients with chronic diseases such as Parkinson's disease and Alzheimer's disease who seek treatment in this specialty, provide comprehensive medical services such as drugs, surgery, rehabilitation training, psychological counseling, and health education consultation, and organize free health education and consultation activities on a regular basis.

6. Apply the latest drugs to treat Parkinson's disease, Alzheimer's disease and other diseases. Use the latest drugs and drug combinations to treat Parkinson's disease, Alzheimer's disease and other diseases.

Conduct clinical drug trials approved by the national drug supervision and testing agency, and patients can try new drugs for free.